Jonathan S. Batchelor

Molecular Imaging
Molecular imaging breaks out as reimbursement expands
Molecular imaging continued its brisk rate of growth in 2004, with U.S. procedure volume in PET imaging set to rise 35% by year-end to about 900,000 studies, compared to the 650,000 procedures performed last year.
November 7, 2004
Mol
Molecular Imaging
Toshiba America Medical Systems
Toshiba America Medical Systems is planning to highlight a new user interface for the T.Cam Signature Series gamma camera, which the Tustin, CA, vendor sources from Siemens Medical Solutions of Malvern, PA. Toshiba will also showcase new applications such as gated tomo acquisition enhancement and new capabilities for dual-isotope studies.
November 7, 2004
Molecular Imaging
Siemens Medical Solutions
Multimodality vendor Siemens Medical Solutions will spotlight its new TruePoint SPECT·CT hybrid imaging system. The product combines the functional sensitivity of SPECT with the anatomical detail of diagnostic multislice CT, according to the Malvern, PA-based vendor.
November 7, 2004
Siemens
Molecular Imaging
Positron
PET developer Positron will be showcasing its mPower whole-body PET scanner optimized for cardiology, oncology, and neurology at the 2004 RSNA meeting. The device has the capability for dynamic and gated cardiac imaging with rubidium-82, according to the Houston-based firm.
November 7, 2004
Molecular Imaging
Philips Medical Systems
Philips Medical Systems will unveil a cornucopia of offerings on the exhibit floor of McCormick Place this year. The Andover, MA-based vendor will be debuting new technology and applications for gamma cameras, PET/CT, and SPECT/CT systems.
November 7, 2004
Molecular Imaging
Naviscan PET Systems
PET developer Naviscan PET Systems of Rockville, MD, will be highlighting its positron emission mammography (PEM) Flex Solo PET scanner in Chicago. The device is a compact PET scanner intended to provide high-resolution images of the breast and guide radiological and surgical procedures.
November 7, 2004
Naviscan
Molecular Imaging
Hitachi Medical Systems America
The SceptreP3 PET/CT will take center stage for Hitachi Medical Systems America. The system received FDA 510(k) marketing clearance in September, and includes a range of image acquisition and processing features, according to the Twinsburg, OH-based company.
November 7, 2004
Hitachi
Molecular Imaging
Gamma Medica
Gamma probe developer Gamma Medica of Northridge, CA, will showcase its X-O micro CT system at the RSNA meeting. The product can acquire whole-body images in less than a minute, and is designed for in vivo preclinical small-animal imaging.
November 7, 2004
Gamma
Molecular Imaging
CTI Molecular Imaging
Radiopharmaceutical developer and PET vendor CTI Molecular Imaging will be debuting PET.Connect. The product is an integrated group of software tools and workstations for image analysis, PET education and marketing, and practice management, according to the Knoxville, TN-based firm.
November 7, 2004
Cti
Molecular Imaging
Delayed PET helps delineate gliomas
Differentiating high-grade gliomas from gray-matter structures with F-18 FDG-PET has been problematic for clinicians because of the brain's avidity for the radiotracer. A recent study from the University of Washington School of Medicine in Seattle presents evidence that extending the interval between FDG administration and PET data acquisition improves the delineation of gliomas from gray matter.
November 4, 2004
2004 10 29 11 07 36 706
Previous Page
Page 47 of 82
Next Page
Top Stories
Knee Oa
Interventional
GAE reduces pain biomarkers in knee osteoarthritis
Genicular artery embolization (GAE) significantly reduces key biomarkers that drive pain in patients with knee osteoarthritis.
Piggy Bank Under Water Adobe Romolo Tavani
Residents/Fellows
Race, ethnicity influence educational debt among radiology-bound MDs
2025 08 14 Rad Cardiothor Firouznia Fig1 Thumbnail
MRI
MRI, CT findings correlate for assessing epicardial fat volume
Medical Bill Final Notice
Practice Management
Imaging experts hope NSA enforcement bill delivers on accountability
Patient Pet
CT
PET/CT identifies bone demineralization in breast cancer patients
More in Home
GPT-4 could prove useful proofreading CT reports
By Will Morton
GPT-4 showed strong performance identifying factual errors in radiology reports, yet struggled to prioritize clinically significant findings.
January 28, 2025
Gpt
Does obesity improve NSCLC patients' postsurgery survival?
By Kate Madden Yee
Obesity appears to improve the overall post-surgery survival of patients with non-small cell lung cancer (NSCLC) by 21% compared with their nonobese peers.
January 28, 2025
2025 01 28 Radiology Lee Figure2 Thumbnail
Global survey shows deep concerns over burnout, workforce shortages
By Amerigo Allegretto and Philip Ward
Burnout, workforce shortages, and locally trained clinicians leaving the field are the top concerns among radiologists worldwide, according to survey findings.
January 27, 2025
Senior Man Ct Scanner
New guidance issued on FAP-PET imaging
By Will Morton
Top U.S. and European nuclear medicine organizations have issued joint guidelines on the use of fibroblast activation protein (FAP)-PET imaging in cancer patients.
January 27, 2025
Cancer Target
IMV: Independent imaging centers face competition for CT scan volume
By Davin Korstjens
Independent imaging centers are experiencing increased competition for CT patients, according to the newly published IMV 2024 CT Market Outlook Report.
January 27, 2025
Ct Scanner Control Room2 Radiologist
Brain MRI tracks risk of stage IV breast cancer metastases
By Kate Madden Yee
Brain MRI shows promise for surveilling women at risk for asymptomatic stage IV breast cancer metastases by tracking molecular subtypes of the disease.
January 24, 2025
Brain Mri
Experts call for CPT codes for imaging AI reimbursement
By Amerigo Allegretto
Imaging AI tools and algorithms continue to be rapidly developed, but experts say reimbursement through CPT codes is needed.
January 24, 2025
Insurance Computer 400
Is herpes infection protective in early Alzheimer’s disease patients?
By Will Morton
In a recent PET study with “unexpected” results, patients infected with herpes had fewer signs of brain deposits associated with Alzheimer’s disease than uninfected patients.
January 24, 2025
Amyloid
Triple-negative breast cancers impact female populations differently
By Amerigo Allegretto
Despite overall breast cancer rate increases, women of varying race and ethnicity experience disproportionately higher increases.
January 24, 2025
Breast Cancer Cell2 Social
What brain mechanisms drive depression in older adults?
By Will Morton
PET has revealed that mechanisms other than amyloid brain deposits may underlie depressive symptoms in people later in life.
January 23, 2025
Ad
MR spectroscopy reveals neurochemical patterns linked to COVID-19
By Kate Madden Yee
Proton MR spectroscopy (MRS) reveals "remarkable" neurochemical patterns associated with COVID-19-induced anosmia, or loss of smell.
January 23, 2025
Mri Brain
LI-RADS ultrasound surveillance version 2024 improves HCC detection
By Amerigo Allegretto
The 2024 version of the LI-RADS Ultrasound Surveillance system improves detection of hepatocellular carcinoma (HCC) over earlier iterations.
January 22, 2025
(A,B) Images from an initial ultrasound examination showed no identifiable lesions and received a consensus ultrasound category of US-1. Nearly the entire liver is visualized, with minimal shadowing (“s”, A and B), and the examination received consensus result of VIS-A. The AFP level was 7.1 ng/mL on assessment six months before the ultrasound, 9.1 ng/mL on assessment three months before examination, and 14.2 ng/mL on assessment on exam day. The AFP result was thus assessed as positive based on a progressive increase on two consecutive tests. The atient was considered to have negative surveillance result according to LI-RADS Ultrasound Surveillance v2017, but positive surveillance result according to LI-RADS Ultrasound Surveillance v2024. (C-D) Axial arterial-phase (C) and portal-venous phase (D) T1-weighted images from subsequent gadoxetic acid-enhanced MRI show a 2-cm arterial-phase hyperenhancing observation (arrow, C) with portal-venous washout (arrow, D) in segment 7. This observation was classified on MRI as LR-5, thus meeting the present study’s reference standard for diagnosis of HCC. The mass is located in the periphery of the liver, an anatomic area where ultrasound visualization can be challenging due to shadowing.
Previous Page
Page 47 of 164
Next Page